Valuation: Camurus AB

Market Cap 31.33B 3.24B 2.84B 2.63B 2.42B 4.56B 312B 4.65B 12.27B 152B 12.18B 11.91B 530B P/E 2026 *
34.4x
P/E 2027 * 21.4x
Enterprise Value 26.88B 2.78B 2.44B 2.25B 2.08B 3.91B 268B 3.99B 10.53B 131B 10.45B 10.22B 455B EV / Sales 2026 *
9.6x
EV / Sales 2027 * 6.8x
Free-Float
67.52%
Yield 2026 *
-
Yield 2027 * -
1 day-2.05%
1 week-8.91%
Current month-6.90%
1 month-2.32%
3 months-1.31%
6 months-23.64%
Current year-14.53%
1 week 525.5
Extreme 525.5
566
1 month 505
Extreme 505
590.5
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
754.5
3 years 275
Extreme 275
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2003
Director of Finance/CFO 57 01/07/2025
Chief Tech/Sci/R&D Officer 58 01/01/2025
Director TitleAgeSince
Director/Board Member 69 01/01/2025
Chairman 77 01/01/2015
Director/Board Member 63 01/01/2002
Date Insider Type Main position Quantity % Market Cap.
02-27Sell

Chief Executive Officer

55,550 0.0928%
02-27Sell

Chief Executive Officer

1,500 0.0025%
02-27Sell

Chief Executive Officer

9,950 0.0166%
Change 5-day change 1-year change 3-year change Capi.($)
-2.05%-8.91%-23.36%+91.59% 3.3B
-2.48%-6.72%+44.19%+156.43% 1,054B
-1.52%-5.01%+61.87%+58.79% 621B
-1.30%-3.88%+27.81%+79.97% 438B
-1.12%-3.68%+26.89%+20.58% 325B
-1.73%-3.45%+26.95%+44.09% 281B
-1.95%-13.92%+15.96%+19.76% 262B
-1.45%-2.37%-27.87%-39.87% 219B
-1.44%-3.49%+19.60%+56.20% 195B
-1.04%-4.63%+16.01%+68.47% 163B
Average -0.93%-2.26%+18.81%+55.60% 355.95B
Weighted average by Cap. -0.19%-1.69%+33.11%+77.06%

Financials

2026 *2027 *
Net sales 2.8B 290M 254M 235M 216M 408M 27.88B 416M 1.1B 13.62B 1.09B 1.06B 47.41B 3.76B 390M 341M 315M 291M 548M 37.48B 559M 1.47B 18.31B 1.46B 1.43B 63.73B
Net income 906M 93.78M 82.11M 75.91M 70.02M 132M 9.02B 135M 355M 4.41B 352M 344M 15.33B 1.45B 150M 131M 121M 112M 211M 14.42B 215M 567M 7.05B 563M 551M 24.52B
Net Debt -4.45B -460M -403M -373M -344M -648M -44.28B -660M -1.74B -21.64B -1.73B -1.69B -75.3B -5.74B -594M -520M -481M -443M -835M -57.11B -852M -2.25B -27.91B -2.23B -2.18B -97.12B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
308
Date Price Change Volume
14/07/26 SEK 526.50 -2.05% 69,616
13/07/26 SEK 537.50 -3.07% 72,062
10/07/26 SEK 554.50 +0.82% 101,864
09/07/26 SEK 550.00 -1.52% 95,389
08/07/26 SEK 558.50 -3.37% 76,734
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
526.50SEK
Average target price
768.12SEK
Spread / Average Target
+45.89%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock